Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida

Similar documents
A systems approach to treating tobacco use and dependence

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

Effective Treatments for Tobacco Dependence

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Tobacco Dependence Treatment From Neurobiology through Public Policy

Smoking Cessation: Treating Tobacco Dependence

Tobacco & Nicotine: Addiction and Treatment

Making Your Business Tobacco Free

PHARMACOTHERAPY OF SMOKING CESSATION

Population-level Strategies to Prevent and Reduce Tobacco Use Success and Challenge

Tobacco Use Dependence and Approaches to Treatment

Smoking Cessation. Disclosures. Thank You. None

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

Adolescents and Tobacco Cessation

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

Pharmacotherapy for Tobacco Dependence Treatment

Addressing Tobacco It Takes a Village

Save Lives and Money. Help State Employees Quit Tobacco

Cigarettes and Other Tobacco Products

Keywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix )

Cigarettes and Other Nicotine Products

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Across the spectrum of available medications designed to assist recovery from

Save a Life in 3 Minutes

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December

Smoking Cessation Strategies: What Works?

Training Healthcare Providers o Deliver Brief Tobacco Interventions Strategies and Impact

Tobacco Dependence Treatment: A Resource Guide. Last Update: 06/2013

Chantix Label Update 2018

Drug Use Evaluation: Smoking Cessation

How to Design a Tobacco Cessation Insurance Benefit

NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1

Brief Intervention for Smoking Cessation. National Training Programme

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):

Nicotine Replacement and Smoking Cessation: Update on Best Practices

Considerations in Designing a Tobacco Services Benefit

TITLE DEPARTMENT OF BUSINESS REGULATIONS

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

Addressing Tobacco Use in Iowa

Availability, Affordability, and Prices of Smoking Cessation Drugs in 9 Countries: Preliminary Findings

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Background. Abstinence rates associated with varenicline

PHD THESIS STUDY ON THE USE OF THE PHARMACOLOGIC THERAPY WITH BUPROPION ON TOBACCO ABSTINENCE FOR SMOKERS WITH HIGH NICOTINE DEPENDENCE

SMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.

Progress toward quitting. The cessation environment in New York

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS

Helping Employees Break the Habit

THE STATE OF MEDICINE IN ADDICTION RECOVERY

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Smoking cessation in mental health & addiction settings. Dr. Susanna Galea Community Alcohol & Drug Services, Auckland October 2013

Pharmacotherapy for Treating Tobacco Dependence

Lindsey White. Tobacco Control Program Coordinator

Smoking Cessation Strategies in 2017

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

WHAT IS THE GUIDELINE

Introduction to pharmacotherapy

Varenicline and Other Pharmacotherapies for Tobacco Dependence

Integrating Tobacco Cessation into Practice

Save Lives and Save Money

Ensuring Medicaid Coverage of Tobacco Cessation

RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits

Best Practices in Tobacco Treatment IDN

Cancer Control Office YOUR GUIDE TO QUIT SMOKING

Smoking It s never too late to quit

Smoking Cessation: A readily modifiable risk factor

PERINATAL TOBACCO USE

Research Into Practice. Translating. Psychological. Translating Psychological Research Into Practice. Grossman Walfish. Steven Walfish.

Collaborating to help Oregon tobacco users quit

PERINATAL TOBACCO USE

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING PDF YOU CAN QUIT SMOKING. QUIT SMOKING CDC 1 / 5

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE

Treating Tobacco Use:

BASIC SKILLS FOR WORKING WITH SMOKERS

Centers for Disease Control and Prevention s Office on Smoking and Health

Cessation Medicine Reference Guide Table of Contents

UPDATE TREATMENT OF TOBACCO USE DISORDERS

Smoking Cessation. Samer Kanaan, M.D.

Tobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses. At-a-Glance:

Brief Counselling for Tobacco Use Cessation

WE QUIT! Between percent of people living with HIV smoke cigarettes. Quitting is one of the biggest steps you can take to stay healthy.

Pharmacologic Therapy for Tobacco Use & Dependence

Report: The Business Case for Coverage of Tobacco Cessation

New Jersey s Comprehensive Tobacco Control Program: Importance of Sustained Funding

Tobacco Control Highlights Wisconsin

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach

9/28/2017. Nicotine Addiction : Past, Present and Future. How to Use this Tutorial. Something to Think About

Executive Summary. Context. Guideline Origins

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019

Transcription:

Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida Thomas H. Brandon, Ph.D. H. Lee Moffitt Cancer Center & Research Institute Florida Tobacco Cessation Summit October 14, 2010

Moffitt Cancer Center National Cancer Institute Designated Comprehensive Cancer Center Dedicated to the prevention and cure of cancer. 4094 Employees; 662 Active Volunteers 732 Research Faculty & Staff 7,742 admissions annually; 289,364 outpatient visits annually $77.2 Million in research grants in 2010 Built with state funds from tobacco taxes.

T.R.I.P. Primary mission: To conduct research on tobacco dependence and its prevention and treatment. Secondary missions: To provide tobacco control services and consultation to region and nation. To train the next generation of tobacco researchers.

T.R.I.P. Largest research group in Florida dedicated solely to studying tobacco dependence. Team of >50: 6 Ph.D. scientists 6 doctoral students 15 research support staff ~25 undergraduate research assistants

Range of Research Basic human laboratory research Brain activity (ERP) associated with nicotine withdrawal Genetic markers of tobacco dependence Translational Applying contemporary models of animal learning to smoking cessation Clinical Trials Self-help smoking cessation booklets Web intervention for college students

Current Cigarette Use among Adults (2008) 30 26.6 Percent Smoking 25 20 15 10 5 20.6 9.2 14 16.8 17.5 19.5 20.1 22.2 0 US UT CA NY FL GA SC AL WV Source: MMWR, 11/13/09

Smoking in Florida Never Smokers 55.3% Former Smokers 27.6% Current Smokers 17.1% Smoke Every Day 12.8% Smoke Some Days 4.3% Source: BRFFS, 2009

Groups With High Prevalence (2008) 45 41.3 40 Percent Smoking 35 30 25 20 15 10 20.6 32.4 27.5 31.5 5 0 US Native Americans No HS Diploma GED Below Poverty Source: MMWR, 11/13/09

Smoking by Age - Florida 30 28.1 Percent Smoking 25 20 15 10 5 17.1 20.7 18 21.6 16.6 7.6 0 Florida 18-24 25-34 35-44 45-54 55-64 65+ Source: BRFFS, 2009

Smoking by Education - Florida 35 33.2 Percent Smoking 30 25 20 15 10 5 17.1 21.1 19.2 8.3 0 Florida < HS HS or GED Some Post-HS College Grad Source: BRFFS, 2009

Smoking by Income - Florida 35 31.9 Percent Smoking 30 25 20 15 10 5 17.1 24.3 19 19.3 14.4 8.4 0 Florida < $15K $15-25K $25-35K $35-50K $50-75K $75K+ Source: BRFFS, 2009

Health Burden of Tobacco Approximately 438,000 Annual U.S. Deaths Attributable to Cigarette Smoking (1997-2001 Data) Stroke 17,400 Other Cancers 34,700 Other Diagnoses 84,600 Lung Cancer 123,800 Source: MMWR 2005: 54, 625-8. Chronic Lung Disease 90,600 Coronary Heart Disease 86,800

Annual Premature Avoidable Deaths 0! 100! 200! 300! 400! 500,000! AIDS" Alcohol" Motor Vehicle" Fires" Homicide" Illicit Drugs" Suicide" Smoking"

Florida Fatalities Average fatalities per 10 years: Shark attacks 2-3 Alligator attacks 10 Lightening strikes 90 Murders 10,000 Tobacco use 300,000

Why do People (Adolescents) Start Smoking? Each day, 3000 U.S. children begin smoking. Why? Adult role models Peer influence Rebellion Stress Beliefs about the positive effects of smoking Delayed health risks not relevant to teens Tobacco advertising enhances all of these effects.

Why Do People Continue Smoking? Nearly 50 million Americans have quit smoking. Yet, nearly another 50 million continue to smoke. Why do they continue, despite all the health warnings and social prohibitions?? Addiction. (Tobacco Dependence)

Tobacco Addiction

Nicotine is Addictive Tolerance Withdrawal Compulsive Use

Nicotine Withdrawal Symptoms (DSM-IV): dysphoric or depressed mood insomnia irritability, frustration, or anger anxiety difficulty concentrating restlessness decreased heart rate increased appetite or weight gain Craving for tobacco Time Course: highly variable, but often begins on Day 1 most symptoms peak Days 2-4 largely resolved by Days 7-10

Nicotine and the Brain Nicotine enters the bloodstream from the lungs upon smoking, then rapidly (~10 secs) reaches the brain. Nicotine acts as a Central Nervous System stimulant, leading to autonomic arousal ( HR, BP, resp). Nicotine has paradoxical effects ( Nesbitt s Paradox"). Nicotine has diverse neurochemical effects: Dopamine Serotonin Glutamate GABA Acetylcholine, cortisol Endogenous opioids (b-endorphin)

Smokers Have Increased Nicotinic Receptors in Prefrontal Cortex

Heritability for Tobacco Use Twin Design: MZ vs. DZ twins Hughes (1986): 3 cohorts - long-term smoker : 53% Sullivan & Kendler (1999): 16 cohorts - smoking initiation: 56% - nicotine dependence: 67% Li, Cheng, Ma, & Swan (2003): 17 cohorts - smoking initiation males: 37% females: 55% - smoking persistence males: 59% females: 46%

Environmental Factors Social groups Availability of tobacco products Cost (price of cigarettes) Opportunity (smoke-free policies)

Psychological Factors Expectations (beliefs) Improves mood Controls weight Makes one social Regulating Negative Mood Increasing attention/concentration. Mental Illness

The tobacco industry exploits all the known addictive factors

How addicting is tobacco? Surveys of addicts. Addiction Index Historical Examples (Germany, Sultan Murad IV, )

Smoking Cessation Treatments Pharmacotherapies double the quitting rate: Nicotine Replacement (patch, gum, inhaler, nasal spray, lozenge) Bupropion SR (Zyban ) Varenicline (Chantix ) So does behavioral counseling: Coping skills, relapse prevention. Best outcomes are with combination of pharmacotherapy and behavioral counseling.

Smoking Relapse To cease smoking is the easiest thing I ever did I ought to know; I've done it a thousand times.

Rate of Relapse % Abstinent 100 90 80 70 60 50 40 30 20 10 0 Heroin Smoking Alcohol 0 1 2 3 4 5 6 7 8 9 10 11 12 Months (Hunt et al., 1971)

Economic Burden of Tobacco Use: Annual Costs National Florida Direct Health Care Expenditures Workplace Productivity Losses $116.4 billion $7.2 billion $67.5 billion $4.4 billion Premature Death $117.1 billion $7.9 billion Total Cost to Economy $301.0 billion $19.6 billion Actual Cost of Pack of Cigarettes $18.05 $16.43 American Lung Association (2010) Smoking Cessation: The Economic Benefits

Cost-Effectiveness of Smoking Interventions Per Quitter Per Life- Year Saved Nicotine patch with minimal counseling $4,745 $3,248 Individual intensive counseling w/o NRT $3,595 $2,461 Intensive group counseling with patch $2,310 $1,581 Cromwell et al. (1997) [add 43% for 2010 dollars]

Cost-Effectiveness (QALY) Intensive counseling w/ patch $1,581 1 HIV blood donor screening $14,000 Flashing lights at rail crossings $42,000 Annual mammography $190,000 Neonatal intensive care $270,000 Universal precautions for HIV $890,000 Ejection system for B-58 bomber $1,200,000 Seat belts in school buses $2,800,000 2 1 Cromwell et al. (1997) 2 Tengs et al. (1995) Treatment of tobacco dependence called the gold standard of healthcare cost-effectiveness (Eddy, 1992).

USPHS Recommendations Recommendation: The tobacco dependence treatments shown to be effective in this guideline (both counseling and medication) are highly cost-effective relative to other reimbursed treatments and should be provided to all smokers. (Strength of Evidence = A)

USPHS Recommendations Recommendation: Providing tobacco dependence treatments (both medication and counseling) as a paid or covered benefit by health insurance plans has been shown to increase the proportion of smokers who use cessation treatment, attempt to quit, and successfully quit. Therefore, treatments shown to be effective in the Guideline should be included as covered services in public and private health benefit plans. (Strength of Evidence = A)

Coverage Makes a Difference 40 35 Percentage 30 25 20 15 10 5 No Coverage Coverage 0 Intervention Rate Quit Attempts Abstinence Rate Source: USPHS, Treating Tobacco Use and Dependence, 2008

Smoking Treatment Coverage: A Sound Investment Estimates for Manufacturing Work Force of 10,000 Employees (1995) Source: Warner et al., J Occup Env Med, 1996.

Smoking Treatment Coverage: Wisconsin Experience (2001-2003) WI Dept of Employee Trust Funds Results A Sound Investment State employees, dependents, retirees Plan offered 3 months of pharmacotherapy 6-7% used smoking cessation benefit annually (17% over three years) Average cost per user: $165.86 Average cost per enrollee: $1.60 Cost per member per month: $0.13 Source: Burns et al., Am J. Prev. Med., 2007

Smoking Treatment Coverage: A Sound Investment Group Health Cooperative (Seattle, 1998-99) Economic Analysis 150-300 mg bupropion (Zyban ) plus phone counseling Results 5-year Return on Investment (ROI): 194-292% Internal Rate of Return (IRR) per year: 24-31% Conclusion: Smoking cessation is profitable for employers. Source: Javitz et al., Value in Health, 2004

Summary Tobacco dependence is a chronic, relapsing, and often fatal disorder. Economic costs are enormous. Significant costs to employers. Tobacco cessation treatments are effective and cost-effective. Providing coverage for treatment is both ethical and profitable for employers.

Disclosures Recent Funding Sources National Cancer Institute National Institute on Drug Abuse National Institute of Alcohol Abuse and Alcoholism American Cancer Society Prevent Cancer Foundation March of Dimes State of Florida Relevant Consulting Pfizer sanofi-aventis